China TCM (570 HK) Buy (maintained) Target price: HK$ H17 earnings beat, 2017 growth guidance reaffirmed; TP raised to HK$5.
|
|
- Ashlynn Merritt
- 6 years ago
- Views:
Transcription
1 Oct-14 Dec-14 Feb-15 Apr-15 Jun-15 Aug-15 Oct-15 Dec-15 Feb-16 Apr-16 Jun-16 Aug-16 Oct-16 Dec-16 Feb-17 Apr-17 Jun-17 Equity Research Healthcare China TCM (570 HK) Buy (maintained) Target price: HK$5.40 Natalie Chiu SFC CE No. AVH GF Securities (Hong Kong) Brokerage Limited 29-30/F, Li Po Chun Chambers 189 Des Voeux Road Central Hong Kong 1H17 earnings beat, 2017 growth guidance reaffirmed; TP raised to HK$5.40 1H17 earnings beat consensus China TCM (CTCM) reported 1H17 revenue/net profit of Rmb3,899/599mn, increases of 21.9%/22% YoY respectively. Bottom line beat consensus and our estimates, coming in at 52% and 54% of Bloomberg and our 2017 forecast respectively. During the analyst briefing, management attributed the strong performance in 1H17 to: 1) solid growth in its concentrated TCM granules business following further network expansion in class-2 and primary healthcare institutions; 2) strong growth in emerging OTC products, offsetting the sales decline in prescription finished drugs, and; 3) effective cost control. In addition, new areas such as its TCM decoction and TCM healthcare complex businesses are providing new sources of growth, and could become prominent growth drivers. The company maintained its full-year sales growth guidance for concentrated TCM granules of, and low-single-digit guidance for finished drugs, although GPM will trend lower on a rising contribution from new businesses and higher raw material costs. Policy on TCM granules standardization to be launched by the year-end or early next year The official announcement of regulations on the administration of concentrated TCM granules, for which a draft for comments was released on Aug 16, will arrive soon, according to the company. Concentrated TCM granules were recently included as a specialty form of decoction piece in the updated Pharmaceutical Law, providing a more legitimate grounding for industry growth. As the industry is not affected by the zero mark-up policy, several provinces are giving preferential treatment to local companies in terms of market limitation and insurance coverage. The company believes the regulation will help improve the operating environment by preventing such protectionism and lead to fair competition. Bright outlook for the ready-to-use decoction business The TCM decoction pieces business represented about 5% of 1H17 revenue and posted 493% YoY growth. It offers an alternative to TCM granules, which requires further manufacturing steps. The company now has decoction centers in Shanghai and Guizhou following its two Tongjitang acquisitions in 4Q16, which will allow customers to extract TCM syrup from decoction pieces. Appropriate systems are in place to receive real-time orders from hospitals, meaning patients do not need to wait during the decoction process. Further, the segment also serves as a bulk business for finished drugs and concentrated TCM granules. The company has plans to acquire smaller extraction companies to accelerate the development of its decoction business. Stock performance AR level to fall in 2H17 Operating cashflow turned negative in 1H17 as a result of: 1) account receivables rising 19% YoY despite lower turnover days of 121 vs 141 in 1H16, and; 2) higher inventory (+9 YoY) due to advanced purchases of high-demand herbs. As the credit period for its TCM granules business averaged about 180 days for direct sales to hospitals, AR should come down by end Source: Bloomberg 570 HK Equity Hang Seng Index Maintain Buy and raise TP from HK$5.00 to HK$5.40 We have revised up our earnings forecasts by 4.8%/1.2% to reflect slightly higher revenue growth assumptions for concentrated TCM granules and lower opex ratios. Hence, we raise our target price from HK$5.00 to HK$5.40, based on a 16% EPS CAGR during , and 1.0x PEG. Risks 1) Lower-than-expected tender prices for its exclusive EDL drugs; 2) Weaker-thanexpected volume growth after withdrawing from tenders; 3) More intense competition after the opening-up of the TMC granules industry. Key data Aug 21 close (HK$) 4.35 Shares in issue (m) Major shareholder Sinopharm HK (36%) Market cap (HK$ bn) M avg. vol. (m) W high/low (HK$) 4.45/2.95 Source: Bloomberg Stock valuation Turnover Net profit EPS EPS YoY P/E BPS P/B ROE (Rmb) (%) (Rmb) (%) , % % , % % 2017E 7,910 1, % E 9,061 1, % % 2019E 10,233 1, % % estimates
2 Figure 1: 1H17 results highlights YoY Chg H16 1H H17 Remarks TCM granules 4,359 2,055 2, % 24% Above guidance of ~ Finished drugs 2,174 1,111 1,144-3% In line TCM decoction pieces % Consolidated financial statements of Shanghai & Guizhou Tongjitang TCM healthcare complex % Contribution from Guizhou Tongjitang Pharmacy Chain Total revenue 6,533 3,199 3,899 76% 22% Gross profit 2,201 1,834 2,170 72% 18% Selling expenses (1,968) (877) (1,022) 65% 17% General and administrative expens (330) (187) (165) 21% -12% No major impairment of receivables R&D expenses (187) (112) (122) 66% 8% EBIT 1, % 27% Finance expenses (73) (34) (85) 5% 149% Due to corporate bonds issued in Nov 2016 and June 2017 Net profit before tax 1, % Income tax expenses (217) (120) (136) 82% 13% Tax rate 17% 18% 17% -0.6ppt -0.1ppt Net profit after tax % 35% Minority interests (120) (54) (64) 548% 18% Reported net profit % 22% Represented 52% of FY17 consensus forecasts EPS: Diluted (Rmb) % 23% Profitability ratios (%) H16 1H H17 Remarks Gross margin % 55.6% -1.3 ppt -1.7ppt Due to raw material cost increases and a bigger contribution from new low-margin businesses Operating margin 21.1% 21.8% 22.7% +0.3pp +0.9pp Net margin 14.8% 15.3% 15.4% -2.1pp +0.1pp Figure 2: Revenue analysis by region (concentrated TCM granules business) H17 YoY chg Region's contribution in 1H17 Eastern China , % 39% Southern China % 19% Northern China % 11% Central China % 1 Northwest China % 7% Northeast China % 7% Southwest China % 6% Other % 1% Figure 3: Revenue analysis by terminal channels (Concentrated TCM granules business) Class III hospitals Class II hospitals TCM hospitals Non-TCM healthcare institutions TCM hospitals Non-TCM healthcare institutions H17 YoY Chg Channel contribution (1H17) TCM hospitals Primary healthcare institutions 378 Non-TCM healthcare institutions % 15% Sales through agents % % 34% 33% 32% Figure 4: Revenue analysis by distribution layers (finished drugs business) 2015 Proportion 2016 Proportion 1H17 Proportion Tier-one distributors 1,759 57% 1,821 65% 2, Tier-two and general distributors 1,313 43% % Total 3, , ,
3 Figure 5: CTCM s finished drugs revenue ( ) Figure 6: CTCM s CCMG business revenue ( ) 3,000 2,500 2,000 1,500 1, % E 2018E Finished products YoY growth (finished products) 7,000 6,000 5,000 4,000 3,000 2,000 1,000-25% % % 1 5% E 2018E Concentrated TCM granules YoY growth (concentrated TCM granules) estimates Figure 7: 12-month forward P/E band Share Price 13x 18x 23x 28x 33x Sources: Bloomberg 3
4 Figure 8: Financial statements Income Statement Balance Sheet Year-end Dec 31 FY15 FY16 FY17E FY18E FY19E Year-end Dec 31 FY15 FY16 FY17E FY18E FY19E Revenue 3,709 6,533 7,910 9,061 10,233 Non-current assets Cost of sales (1,509) (2,745) (3,522) (4,041) (4,584) PP&E 1,669 2,019 2,300 2,531 2,713 Gross profit 2,201 3,788 4,388 5,020 5,649 Investment properties Deposits and prepayments Other income Prepaid lease payments Selling and distribution expenses (1,196) (1,968) (2,105) (2,446) (2,763) Goodwill 3,341 3,456 3,456 3,456 3,456 Administration expenses (273) (330) (348) (408) (460) Intangible assets 6,680 6,764 6,817 6,866 6,911 Operating profit 761 1,377 1,741 1,966 2,197 Interest in JV and associate Net finance income (cost) (70) (73) (173) (210) (209) Deferred tax assets Other non-recurring items (2) 0 (4) 0 0 Other financial assets Profit before tax 689 1,304 1,565 1,755 1,988 12,336 12,966 13,453 13,847 14,188 Income tax expense (119) (217) (266) (298) (338) Net profit 644 1,087 1,299 1,457 1,650 Current assets Minority interests (18) (120) (130) (146) (165) Inventories 1,236 1,894 2,062 2,477 2,672 Net profit attributable to shareholders ,169 1,311 1,485 Trade and other receivables 3,398 2,716 4,652 3,789 5,743 EPS (Rmb) Other current assets Pledged bank deposits Growth rates (%) Fixed deposits 0 1,050 1,050 1,050 1,050 Revenue % 21.1% 14.6% 12.9% Bank balance and cash 2,102 2,373 4,305 4,490 5,053 Adjusted net profit 51.4% 54.6% 20.9% 12.2% 13.2% 6,878 8,070 12,068 11,806 14,518 Adjusted EPS 4.1% % 12.2% 13.2% Total assets 19,214 21,037 25,521 25,652 28,706 Margin & ratios (%) Gross margin 59.3% % 55.4% 55.2% Current liabilities OP margin 20.5% 21.1% % 21.5% Trade and other payables 2,660 2,304 4,064 3,132 5,032 Net margin 16.9% 14.8% 14.8% 14.5% 14.5% Current portion of deferred govt grants Effective tax rate 17.3% 16.7% Tax liabilitites Payout ratio % Bank borrowings 1,600 1, ,485 3,507 5,066 4,134 6,034 Cash Flow Statement Non-current liabilities Year-end Dec 31 FY15 FY16 FY17E FY18E FY19E Deferred tax liabilities 1,669 1,723 1,723 1,723 1, Borrowings Profit before tax 763 1,304 1,565 1,755 1,988 Unsecured notes 0 2,486 4,486 4,486 4,486 Depreciation and amortization Government grants Net finance cost (income) (25) ,589 4,774 6,751 6,751 6,701 Others (39) Change of working capital (189) (47) (340) (485) (250) Equity Tax paid (149) (204) (250) (281) (318) Shareholders' equity 11,133 11,588 12,407 13,324 14,364 Operating cash flow 519 1,465 1,508 1,609 2,086.9 Minority interests 1,007 1,168 1,297 1,443 1,608 12,140 12,756 13,704 14,768 15,972 Capex (7,677) (1,531) (850) (850) (850) Change of AFS investments Total liabilities & equity 19,214 21,037 25,521 25,652 28,706 Interest received Others 129 (984) (20) (20) (20) Financial Ratios Investing cash flow (7,158) (2,500) (861) (860) (859) Year-end Dec 31 FY15 FY16 FY17E FY18E FY19E Change of borrowings 1,202 1,821 1,776 0 (50) Current ratio Proceeds from issue of shares 7, Quick ratio Dividend distribution 0 (59) (140) (170) (170) Others (72) (634) (351) (393) (445) Asset turnover Financing cash flow 8,330 1,128 1,285 (564) (665) Total assets/total equity ,903 Net cash/(debt) (312) (484) (331) (146) 467 Net change of cash flow 1, , Gearing ratio (%) 22% 34% 46% 43% 39% Forex changes (28) Cash and cash equivalents at beginning 439 2,102 2,373 4,305 4,490 ROE (%) 9% 9% 1 11% 11% Cash and cash equivalents at end 2,102 2,194 4,305 4,490 5,053 ROA (%) 5% 5% 6% 5% 6% estimates 4
5 Rating definitions Benchmark: Hong Kong Hang Seng Index Time horizon: 12 months Company ratings Buy Stock expected to outperform benchmark by more than 15% Accumulate Stock expected to outperform benchmark by more than 5% but not more than 15% Hold Expected stock relative performance ranges between -5% and 5% Underperform Stock expected to underperform benchmark by more than 5% Sector ratings Positive Sector expected to outperform benchmark by more than 1 Neutral Expected sector relative performance ranges between -1 and 1 Cautious Sector expected to underperform benchmark by more than 1 Analyst Certification The research analyst(s) primarily responsible for the content of this research report, in whole or in part, certifies that with respect to the company or relevant securities that the analyst(s) covered in this report: (1) all of the views expressed accurately reflect his or her personal views on the company or relevant securities mentioned herein; and (2) no part of his or her remuneration was, is, or will be, directly or indirectly, in connection with his or her specific recommendations or views expressed in this research report. Disclosure of Interests (1) The proprietary trading division of GF Securities (Hong Kong) Brokerage Limited ( GF Securities (Hong Kong) ) and/or its affiliated or associated companies do not hold any shares of the securities mentioned in this research report. (2) GF Securities (Hong Kong) and/or its affiliated or associated companies do not have any investment banking relationship with the companies mentioned in this research report in the past 12 months. (3) Neither the analyst(s) preparing this report nor his/her associate(s) serves as an officer of the company mentioned in this report and has any financial interests or hold any shares of the securities mentioned in this report. Disclaimer This report is prepared by GF Securities (Hong Kong). It is published solely for information purpose and does not constitute an offer to buy or sell any securities or a solicitation of an offer to buy, or recommendation for investment in, any securities. The research report is intended solely for use of the clients of GF Securities (Hong Kong). The securities mentioned in the research report may not be allowed to be sold in certain jurisdictions. No action has been taken to permit the distribution of the research reports to any person in any jurisdiction that the circulation or distribution of such research report is unlawful. No representation or warranty, either express or implied, is made by GF Securities (Hong Kong) as to their accuracy and completeness of the information contained in the research report. GF Securities (Hong Kong) accepts no liability for all loss arising from the use of the materials presented in the research report, unless is excluded by applicable laws or regulations. Please be aware of the fact that investments involve risks and the price of securities may be fluctuated and therefore return may be varied, past results do not guarantee future performance. Any recommendation contained in the research report does not have regard to the specific investment objectives, financial situation and the particular needs of any individuals. The report is not to be taken in substitution for the exercise of judgment by respective recipients of the report, where necessary, recipients should obtain professional advice before making investment decisions. GF Securities (Hong Kong) may have issued, and may in the future issue, other communications that are inconsistent with, and reach different conclusions from, the information presented in the research report. The points of view, opinions and analytical methods adopted in the research report are solely expressed by the analysts but not that of GF Securities (Hong Kong) or its affiliates. The information, opinions and forecasts presented in the research report are the current opinions of the analysts as of the date appearing on this material only which may subject to change at any time without notice. The salesperson, dealer or other professionals of GF Securities (Hong Kong) may deliver opposite points of view to their clients and the proprietary trading division with respect to market commentary or dealing strategy either in writing or verbally. The proprietary trading division of GF Securities (Hong Kong) may have different investment decision which may be contrary to the opinions expressed in the research report. GF Securities (Hong Kong) or its affiliates or respective directors, officers, analysts and employees may have rights and interests in securities mentioned in the research report. Recipients should be aware of relevant disclosure of interest (if any) when reading the report. Copyright GF Securities (Hong Kong) Brokerage Limited. Without the prior written consent obtained from GF Securities (Hong Kong) Brokerage Limited, any part of the materials contained herein should not (i) in any forms be copied or reproduced or (ii) be re-disseminated. GF Securities (Hong Kong) Brokerage Limited. All rights reserved /F, Li Po Chun Chambers, 189 Des Voeux Road Central, Hong Kong Tel: Fax: Website: 5
Goodbaby (1086 HK) Buy (maintained) Target price: HK$ H16 results miss, but margin expansion continues. Equity Research Consumer Discretionary
Equity Research Consumer Discretionary Goodbaby (1086 HK) Buy (maintained) Target price: HK$4.20 1H16 results miss, but margin expansion continues Maintain Buy Net profit rose 21% YoY to HK$107m in 1H16,
More informationAnta Sports (2020 HK)
Equity Research Consumer Discretionary Anta Sports (2020 HK) Hold (downgraded) Target price: HK$22.80 Albert Yip, CFA SFC CE No. ADT599 albertyip@gfgroup.com.hk +852 3719 1010 GF Securities (Hong Kong)
More informationLuk Fook (590 HK) Hold Target price: HK$ Downgrade to Hold on more challenging HK & Macau market outlook. Equity Research Consumer Discretionary
Equity Research Consumer Discretionary Luk Fook (590 HK) Hold Target price: HK$24.60 Albert Yip, CFA SFC CE No. ADT599 albertyip@gfgroup.com.hk +852 3719 1010 GF Securities (Hong Kong) Brokerage Limited
More informationDaphne (210 HK) Hold (maintained) Target price: HK$1.07. Takeaways from company visit. Equity Research Consumer Discretionary.
Equity Research Consumer Discretionary Daphne (21 HK) Hold (maintained) Target price: HK$1.7 Takeaways from company visit Maintain Hold We recently visited Daphne to gain a more in-depth insight into its
More informationAnta Sports (2020 HK)
Equity Research Consumer Discretionary Anta Sports (2020 HK) Buy (maintained) Target price: HK$18.50 Strong FY14 results; order book momentum maintained FY14 results above expectation Net profit jumped
More informationAnta Sports (2020 HK)
Equity Research Consumer Discretionary Anta Sports (2020 HK) Buy (maintained) Target price: HK$18.50 Product mix improvement in 4Q15 order book 4Q15 order book kept at low-teen, better product mix Order
More informationChow Sang Sang (116 HK)
Equity Research Consumer Discretionary Chow Sang Sang (116 HK) Hold (maintained) Target price: HK$14.00 1H16 China sales outperformed peers; still cautious on HK market Maintain Hold We revise down our
More informationChow Tai Fook (1929 HK)
Equity Research Consumer Discretionary Chow Tai Fook (1929 HK) Accumulate Target price: HK$11.60 3QFY15 sales disappoint SSS plunge 21% YoY in HK and Macau The sluggish sales was attributable to protest
More informationChow Tai Fook (1929 HK)
Equity Research Consumer Discretionary Hold (maintained) Target price: HK$8.50 Albert Yip, CFA SFC CE No. ADT599 albertyip@gfgroup.com.hk +852 3719 1010 GF Securities (Hong Kong) Brokerage Limited 29-30/F,
More informationKingsoft (3888 HK) Buy (maintained) Target price: HK$ Q16 results in line, renewed growth outlook; maintain Buy with target price of HK$20.
Equity Research Information Technology Kingsoft (3888 HK) Buy (maintained) Target price: HK$2.77 2Q16 results in line, renewed growth outlook; maintain Buy with target price of HK$2.77 2Q16 results in
More informationLuk Fook (590 HK) Hold (downgraded) Target price: HK$ HFY18 results beat, but downgrade from Accumulate to Hold on rich valuation
Equity Research Consumer Discretionary Luk Fook (590 HK) Hold (downgraded) Target price: HK$34.80 Albert Yip, CFA SFC CE No. ADT599 albertyip@gfgroup.com.hk +852 3719 1010 GF Securities (Hong Kong) Brokerage
More informationKingsoft (3888 HK) Buy (maintained) Target price: HK$ Strong earnings recovery ahead amid continued revenue momentum; maintain Buy
Equity Research Information Technology Mar 29, 216 Kingsoft (3888 HK) Buy (maintained) Target price: HK$24.7 Strong earnings recovery ahead amid continued revenue momentum; maintain Buy FY1 results in
More informationLuk Fook (590 HK) Strong 1Q gem-set SSS in China. Core profit (HK$ m) Net profit (HK$ m) Turnover (HK$ m)
Equity Research Consumer Discretionary Luk Fook (590 HK) Hold (maintained) Target price: HK$23.10 Strong 1Q gem-set SSS in China China gem-set SSS outperformed CTF SSS in China improved from -5% in 1QFY15
More informationLuk Fook (590 HK) Hold (maintained) Target price: HK$ In line results, 1QFY17 remains weak. Equity Research Consumer Discretionary.
Equity Research Consumer Discretionary Luk Fook (590 HK) Hold (maintained) Target price: HK$16.50 In line results, 1QFY17 remains weak In line results Net profit slumped 41% YoY to HK$959m in 1QFY17, in
More informationKingsoft (3888 HK) Buy (maintained) Target price: HK$20.77
Equity Research Information Technology May 24, 216 Kingsoft (3888 HK) Buy (maintained) Target price: HK$2.77 Full-year earnings forecast trimmed as 1Q16 results miss; maintain Buy but lower target price
More informationCRRC (1766 HK) Accumulate (maintained) Target price: HK$8.20. Weak 1H17 results, but management s optimistic view on EMU orders eases market concern
Equity Research Rail Equipment CRRC (1766 HK) Accumulate (maintained) Target price: HK$8.2 Dominic Chan, CFA, FRM SFC CE No. APP69 dominicchan@gfgroup.com.hk +852 3719 1218 GF Securities (Hong Kong) Brokerage
More informationPeak Sport (1968 HK)
Equity Research Consumer Discretionary Sport (1968 HK) Buy (maintained) Target price: HK$2.41 Signing of NBA All-Star player to enhance brand equity and ease concerns Signing of Dwight Howard to enhance
More informationPICC Group (1339 HK)
Equity Research Financials PICC Group (1339 HK) Accumulate (Maintained) Target price: HK$4.40 Company undervalued; maintain Accumulate Positive signs for both the P&C sector in China and PICC P&C We see
More informationYuexiu REIT (405 HK)
Equity Research Property Yuexiu REIT (405 HK) Buy (initiation) Target price: HK$5.90 Premium investment property portfolio, attractive dividend yield; initiate at Buy First HK-listed China property REIT,
More informationIGG (799 HK) Buy (maintained) Target price: HK$3.75. Strengthened global operation and development capability; maintain Buy but cut TP to HK$3.
Equity Research Information Technology IGG (799 HK) Buy (maintained) Target price: HK$3.7 Strengthened global operation and development capability; maintain Buy but cut TP to HK$3.7 Lowerthanexpected 2Q
More informationGeely Auto (175 HK) EPS (Rmb) Turnover (Rmb m) Net profit. Sources: Company data, GF Securities (Hong Kong)
Equity Research Auto Geely Auto (175 HK) Buy (maintained) Target price: HK$ 33.29 Chongjing Deng SFC CE No. BEY953 dengchongjing@gf.com.cn +86 2 8757 6482 GF Securities (Hong Kong) Brokerage Limited 29-3/F,
More informationChina Modern Dairy (1117 HK)
Equity Research Consumer staples China Modern Dairy (1117 HK) Underperform (Downgraded) Target price: HK$2.75 ASP outlook worsens on China Mengniu settlement price cut Milk powder inventory destocking
More informationXtep International (1368 HK)
Equity Research Consumer Discretionary International (1368 HK) Hold (Initiation) Target price: HK$3.66 Albert Yip, CFA SFC CE No. ADT599 albertyip@gfgroup.com.hk +852 3719 1010 GF Securities (Hong Kong)
More informationJewelry Sector. YTD HK market stronger-than-expected; FY18 results could beat. Equity Research Consumer Discretionary. Mar 12, 2018.
Equity Research Consumer Discretionary Jewelry Sector YTD HK market stronger-than-expected; FY18 results could beat Albert Yip, CFA SFC CE No. ADT599 albertyip@gfgroup.com.hk +852 3719 1010 GF Securities
More informationBrilliance China (1114 HK)
Equity Research Consumer Discretionary Brilliance China (1114 HK) Buy (maintained) Target price: HK$25.75 New 5 Series continues to drive new product cycle, highly anticipated X3 SUV to be launched in
More informationLeju Holdings (LEJU US)
Equity Research Property Leju Holdings (LEJU US) Hold (Initiation) Target price: US$16.00 Fairly valued major real estate services provider; initiate at Hold Major real estate services provider in China
More informationChina Life Insurance Sector
Research Sector Report Hong Kong China Undervalued; Maintain Positive on long-term outlook China has released a series of policies for the insurance sector following the third Plenum of China. Some policies
More informationChinese Banking Sector
Equity Research Financials Jan 17, 218 Chinese Banking Sector Positive (maintained) Strong loan demand expected; intensified competition in deposits Wang Wen SFC CE No. BGL298 wangwen@gfgroup.com.hk +86
More informationHK Retail Sector Monthly
Equity Research Consumer Discretionary May 4, 218 HK Retail Sector Monthly March retail sales jump 11.2%; momentum continued into April and Labor Day holiday Albert Yip, CFA SFC CE No. ADT599 albertyip@gfgroup.com.hk
More information2018 Insurance Sector Outlook
Equity Research Financials 2018 Insurance Sector Outlook Positive (maintained) Felix Luo SFC CE No. AQF573 felixluo@gfgroup.com.hk +852 3719 1048 GF Securities (Hong Kong) Brokerage Limited 29-30/F, Li
More informationChina P&C Insurance Sector
Research Sector Report Hong Kong China Valuation not attractive enough; Downgrade to Neutral Industry-wide Combined Ratio has increased since 2013. For example, PICC P&C s (02328) aggregate combined ratio
More informationChina Property Monthly
Research Sector Report China Property Monthly Hong Kong China GFA sold declined by 6.9% yoy as of April GFA sold declined by 6.9% yoy as of April. According to China NBS, as of April 2014, real estate
More information2H17 Securities Sector Outlook
Equity Research Financials 2H17 Securities Sector Outlook Positive outlook for Chinese brokers in Hong Kong Felix Luo SFC CE No. AQF573 felixluo@gfgroup.com.hk +852 3719 1048 GF Securities (Hong Kong)
More informationConstruction Machinery Sector
Equity Research Construction Machinery Construction Machinery Sector Positive (maintained) Dec sales update; price hikes likely in China s excavator market Dominic Chan, CFA, FRM SFC CE No. APP609 dominicchan@gfgroup.com.hk
More information2018 A-Share Market Strategy
Equity Research 2018 A-Share Market Strategy Favor high growth mid-caps that are improving their product offerings Alex Fan, CFA SFC CE No. ADJ672 alexfan@gfgroup.com.hk +852 3719 1047 With contribution
More informationYuexiu Property (123 HK)
Equity Research Property Yuexiu Property (123 HK) Buy (initiation) Target price: HK$1.70 Earnings to resume growth in 2017; initiate at Buy Major Guangzhou developer focused on residential property Previously
More informationSunny Optical (2382 HK)
Equity Research Tech Hardware Optical (2382 HK) Industry leadership continues to strengthen on optical and optoelectronic products Ou Yafei SFC CE No. BFN41 oyf@gf.com.cn +86 2 8757 39 GF Securities (Hong
More informationFar East Horizon (3360 HK)
Equity Research Financials Far East Horizon (3360 HK) Buy (upgraded) Target price: HK$9.30 Wang Wen SFC CE No. BGL298 wangwen@gfgroup.com.hk +86 755 8826 1286 GF Securities (Hong Kong) Brokerage Limited
More informationMaple Leaf (1317 HK)
Equity Research Consumer Discretionary Maple Leaf (1317 HK) Buy (maintained) Target price: HK$8.00 Student number below expectation, but company still benefitting from China s rising middle class Albert
More informationDim Sum Express. A-Share Market. Hong Kong Market. Equity Research. Mar 23, 2016
Equity Research Dim Sum Express Key index performance Chg (%) EPS (%) P/E Market 1D 1M YTD 15E 16E 15E 16E HSI -0.1 6.4-5.7 11.4 3.6 9.8 9.5 HSCEI -0.3 8.9-7.9 9.2-1.2 6.5 6.5 MXCN -0.1 8.2-5.6 13.8 4.1
More information2H18 Hong Kong Market Strategy
Equity Research Investment Strategy 2H18 Hong Kong Market Strategy Focus on stocks related to domestic demand amid volatility Ou Yafei SFC CE No. BFN410 oyf@gf.com.cn +86 20 8757 3009 GF Securities (Hong
More informationChow Tai Fook (1929 HK)
Equity Research Consumer Discretionary Chow Tai Fook (1929 HK) Accumulate (initiation) Target price: HK$11.70 Albert Yip, CFA SFC CE No. ADT599 albertyip@gfgroup.com.hk +852 3719 1010 GF Securities (Hong
More informationUS 10Y Treasury Yield: Framework and Forecasts
US Y Treasury Yield: Framework and Forecasts Minggao Shen, PhD SFC CE No. ATQ771 minggaoshen@gfgroup.com.hk + 719 Jianghui Chen, PhD SFC CE No. BLG georgechen@gfgroup.com.hk + 719 Thanks to Zheng Ying*
More informationIndustrial Robots. Breakthrough for core components; import substitution accelerating. Equity Research Machinery. Jun 21, 2018
Equity Research Machinery Industrial Robots Breakthrough for core components; import substitution accelerating Ou Yafei SFC CE No. BFN410 oyf@gf.com.cn +86 20 8757 3009 GF Securities (Hong Kong) Brokerage
More informationChina Banking Sector
Equity Research Financials China Banking Sector Positive (maintained) Wang Wen SFC CE No. BGL298 wangwen@gf.com.cn +86 755 8826 1286 With contribution from the GF A-share research team. GF Securities (Hong
More informationDim Sum Express. A-Share Market. Hong Kong Market. Equity Research. May 5, 2017
Equity Research Dim Sum Express Key index performance Chg (%) EPS (%) P/E Market 1D 1M YTD 17E 18E 17E 18E HSI -0.1 1.2 12.2 10.2 9.4 12.3 11.2 HSCEI -0.8-2.7 7.4 1.1 9.1 8.1 7.5 MXCN -0.8 1.0 15.7 14.0
More informationExport-oriented dividend yield play; initiate at Hold. Net profit (US$ m) Turnover (US$ m) YoY chg (%)
Equity Research Information Technology VTech (303 HK) Hold (initiation) Target price: HK$109.00 Exportoriented dividend yield play; initiate at Hold Initiate at Hold We initiate coverage of VTech with
More informationChina Pulse Check: Coal Sector
Equity Research China Pulse Check China Pulse Check: Coal Sector Thermal coal price stabilized, eyes on maintenance of the Daqin line and winter restocking Ou Yafei SFC CE No. BFN41 oyf@gf.com.cn +86 2
More informationDim Sum Express. A-Share Market. Equity Research. Jun 27, 2018
Equity Research Dim Sum Express Key index performance Chg (%) EPS (%) P/E Market 1D 1M YTD 18E 19E 18E 19E HSI -0.3-5.6-3.5 40.7 10.5 11.4 10.3 HSCEI -0.8-7.7-5.0 21.4 10.3 7.6 6.9 MXCN -0.6-5.5-1.7 54.4
More informationDim Sum Express. A-Share Market. Hong Kong Market. Equity Research. May 10, 2016
Equity Research Dim Sum Express Key index performance Chg (%) EPS (%) P/E Market 1D 1M YTD 15E 16E 15E 16E HSI 0.2-1.0-8.0 10.5 10.5 9.8 8.9 HSCEI -0.3-2.9-12.5 9.3 7.6 6.4 5.9 MXCN -0.3-3.2-9.3 13.8 10.3
More informationChina Pulse Check: Steel Sector
Equity Research Sector Watch China Pulse Check: Steel Sector Prices to grow moderately in May, sector earnings to improve significantly Ou Yafei SFC CE No. BFN410 oyf@gf.com.cn +86 20 8757 3009 GF Securities
More informationLuk Fook (590 HK) Buy (initiation) Target price: HK$ Strong China growth, undemanding valuation; initiate at Buy
Equity Research Consumer Discretionary Luk Fook (59 HK) Buy (initiation) Target price: HK$28.8 Albert Yip, CFA SFC CE No. ADT599 albertyip@gfgroup.com.hk +852 3719 11 GF Securities (Hong Kong) Brokerage
More informationMarket Snapshot. Further re-rating of low valuation sectors ahead; high growth sectors to recover. Equity Research Investment Strategy.
Equity Research Market Snapshot Further re-rating of low valuation sectors ahead; high growth sectors to recover Alex Fan, CFA SFC CE No. ADJ672 alexfan@gfgroup.com.hk +852 3719 1047 GF Securities (Hong
More informationPapermaking Sector. Waste import regulations coming into effect; still positive on domestic waste price increases. Equity Research Light Industry
Equity Research Light Industry Papermaking Sector Waste import regulations coming into effect; still positive on domestic waste price increases Alex Fan, CFA SFC CE No. ADJ672 alexfan@gfgroup.com.hk +852
More informationA-Share Securities Sector
Equity Research Financials AShare Securities Sector Trading recovered; 19 listed brokers saw May net profit up 24% Ou Yafei SFC CE No. BFN410 oyf@gf.com.cn +86 20 8757 3009 GF Securities (Hong Kong) Brokerage
More informationTargeted RRR cut. Targeted RRR cut not signifying a reversal in neutral monetary policy. Equity Research Investment Strategy.
Equity Research Investment Strategy Targeted RRR cut Targeted RRR cut not signifying a reversal in neutral monetary policy Ou Yafei SFC CE No. BFN410 oyf@gf.com.cn +86 20 8757 3009 GF Securities (Hong
More informationDim Sum Express. A-Share Market. Hong Kong Market. Equity Research. Jul 6, 2016
Equity Research Key index performance Chg (%) EPS (%) P/E Market 1D 1M YTD 15E 16E 15E 16E HSI -1.5-1.3-5.3 10.2 10.5 10.4 9.4 HSCEI -1.8-2.5-10.5 8.8 8.5 6.8 6.2 MXCN -1.4-1.4-6.8 14.9 12.6 10.0 8.9 SHSZ300
More information2018 A-Share Defense Sector Outlook
Equity Research Defense Sector 218 A-Share Defense Sector Outlook Sector likely to experience upcycle over next three years Alex Fan, CFA SFC CE No. ADJ672 alexfan@gfgroup.com.hk +852 3719 147 GF Securities
More information2018 Healthcare Sector Outlook
Equity Research Healthcare 2018 Healthcare Sector Outlook Favorable structural changes to drive earnings growth in 2018 Natalie Chiu SFC CE No. AVH029 nataliechiu@gfgroup.com.hk +852 3760 2030 GF Securities
More informationElectrode Foil Industry
Equity Research Electrode Foil Industry Electrode Foil Industry Supply still weaker than demand, prices to continue to rise Ou Yafei SFC CE No. BFN410 oyf@gf.com.cn +86 20 8757 3009 GF Securities (Hong
More informationYili ( CH) Improved margins in 1Q17 May 8, 2017
Yili (600887 CH) Improved margins in 1Q17 In 1Q17, Yili s revenue, gross profit, and net profit grew 3.03% YoY, 10.49% YoY and 11.58% YoY The Group s NPM improved from 9.34% in FY16 to 10.98% in 1Q17;
More informationWe expect Hang Seng Index to test 27,000 in the worst scenario. Market Overview. Hang Seng Index Performance
27 August 2018 Hang Seng Index Performance Major Market Indicators % Cha nge Hong Kong Close 1- Da y 1- Mth 6 - Mth 12 - Mth Hang Seng Index 27,671.87-0.4% - 3.9% - 11.5% - 0.6% HSCEI (H- Shares) 10,779.71-0.3%
More informationWH Group (288 HK) 3Q17 growth continued to pick up Nov 20, 2017
WH Group (288 HK) 3Q17 growth continued to pick up 3Q17 growth momentum picked up and OPM continued to improved; NPM was lower than that of previous quarters Geographical segments saw varying performance
More informationCrude Oil Price Outlook
Crude Oil Price Outlook Positivity from risk appetite, supply-demand structure and Middle East tensions Minggao Shen SFC CE No. ATQ771 minggaoshen@gfgroup.com.hk +852 3719 1055 GF Securities (Hong Kong)
More informationKingboard Laminates (1888 HK)
Equity Research Information Technology Kingboard Laminates (1888 HK) Accumulate (initiation) Target price: HK$3.44 Value and dividend yield play; initiate at Accumulate Initiation at Accumulate rating
More informationWe expect Hang Seng Index to be highly volatile in the short term. Market Overview
8 November 2018 Hang Seng Index Performance Major Market Indicators % Change Hong Kong Close 1-Day 1-Mth 6-Mth 12-Mth Hang Seng Index 26,147.69 0.1% -0.2% -14.0% -9.5% HSCEI (H-Shares) 10,641.48 0.1% 2.4%
More information2H18 Hong Kong TMT Sector Outlook
Equity Research TMT 2H18 Hong Kong TMT Sector Outlook Optical leaders benefiting from increased penetration of dual-cameras and 3D sensing; semiconductors to enter development upcycle Ou Yafei SFC CE No.
More informationHaitong Securities [6837.HK]
July 14, 2015 Haitong Securities [6837.HK] Solid 1H Result Provides Buffer; Margin Financing Risk Manageable We believe a 36% correction of Haitong Securities (HTS) share price since early June has been
More information2H16 Power Equipment Sector Outlook
Equity Research Industrials 2H16 Power Equipment Sector Outlook Opportunities in power grid construction Dominic Chan, CFA, FRM SFC CE No. APP609 dominicchan@gfgroup.com.hk +852 3719 1218 GF Securities
More informationInline 2017 results Net profit up 52% yoy; Maintain BUY
2 March 2018 Company update Environment Inline 2017 results Net profit up 52% yoy; Maintain BUY reported an inline FY2017 results with profit up 52% yoy and core earnings up 45% yoy Biomass construction
More informationCompany Report. TCL Comm (2618 HK) Strong FY15E ahead backed by solid product roadmap in smartphone/wearables/apps/cloud; Reiterate BUY BUY
Company Report China Merchants Securities (HK) Co.Ltd. Hong Kong Equity Research TCL Comm (2618 HK) Strong FY15E ahead backed by solid product roadmap in smartphone/wearables/apps/cloud; Reiterate BUY
More informationAnhui Conch [0914.HK]
Anhui Conch [0914.HK] Due to high base effect in 1H14 and weak cement price trend year-to-date, we forecast Anhui Conch s 1H15 recurring net profit to decline 41% year-on-year (YoY) to RMB3.45bn. As a
More informationChinasoft International (0354 HK)
Equity Research Tech, Media & Telecom 11 Jun 2014 Chinasoft International (0354 HK) SaaS initiative in cloud business Advancing in SaaS cloud with government and corporates demand: Following exclusive
More informationEarnings sustainability and asset quality remain under pressure
Bank of Chongqing (1963 HK; TP H KD6.85; H OLD) Bank of Chongqing (1963 HK) Equity Research Earnings sustainability and asset quality remain under pressure Huatai Research 30 October 2017 Equity China
More informationBUY CMEC [1829.HK] May 19, More new flow on overseas contract is expected to come under, upgrade to BUY. Infrastructure Sector
CMEC [9.HK] More new flow on overseas contract is expected to come under, upgrade to BUY A total of US$21bn of major economic corporation contracts were signed (or reinforced) after the visiting activities
More informationSilicon Works (108320)
Company Note June 8, 2018 12M rating BUY (Maintain) OLED growth starts with Silicon Works 12M TP W56,000 Up/downside +38% from W56,000 2Q18 OP to surge 165% YoY to W8.4bn Despite disappointing 1Q18 results,
More informationDim Sum Express. A-Share Market. Hong Kong Market. Equity Research. Jun 24, 2016
Equity Research Key index performance Chg (%) EPS (%) P/E Market 1D 1M YTD 15E 16E 15E 16E HSI 0.4 5.2-4.8 10.3 10.1 10.3 9.4 HSCEI 0.3 5.8-9.1 8.7 8.2 6.8 6.3 MXCN 0.2 3.6-6.7 14.5 12.5 9.9 8.8 SHSZ300-0.5
More informationOilfield Services & Equipment Sector
11/13 1/14 3/14 5/14 7/14 9/14 Equity Research Energy Nov 11, 214 Oilfield Services & Equipment Sector Neutral (Maintained) Weak sentiment to last longer than expected Shrinking margin and higher depreciation
More information23,315 PRICE: HK$3.55 EARNINGS
Recommendation: BUY TP: HK$4.87(+37.2%) Comba Telecom Systems Holdings Limited (2342.HK) 06 October 2014 SECTOR: Telecom Equipment HSI: 23,315 PRICE: HK$3.55 EARNINGS (reported in HK$m) KEY DATA For the
More informationGathering momentum. BUY Target Price: HK$2.70 (+37%) Price: HK$1.97 HKEx Code: 206 Mon, 28 Mar Result Update. Key points:
Mar-10 May-10. Jul-10 Sep-10 Nov-10 Jan-11 Mar-11 TSC Group (TSC 集團 ) BUY Target Price: HK$2.70 (+37%) Price: HK$1.97 HKEx Code: 206 Mon, 28 Mar 2011 Gathering momentum Equity Research Oil & Gas equip/
More informationHOLD BUY. China Singyes Solar Technologies [0750.HK] Outlook improving but positives largely priced in after recent share price rally
September February 27, 1, 2015 2016 China Singyes Solar Technologies [0750.HK] Outlook improving but positives largely priced in after recent share price rally Singyes s 1H16 earnings growth of 42% YoY
More informationCR Lands. Winner of next 5 years, BUY. March 21, 2018 Equity Research. Stock code: 1109.HK Rating: BUY Price target (HK$) 34.74
Equity Research Winner of next 5 years, BUY 2017 result: slow growth, but high profitability Revenue slightly improved by 8.5% YoY to HKD 118.5 bn. Thanks to GPM growing by 6.5 pts to 40%, gross profit
More informationKWG. Seeking balance between scale and profitability. March 27, 2018 Equity Research. Stock code: 1813.HK Rating: HOLD Price target (HK$) 12.
Equity Research Seeking balance between scale and profitability Downgrade to HOLD and revise down TP to HK$12.50: 2017 result missed our estimation; core net profit dropped by 19% YoY, expansion execution
More informationDRAGON CROWN GROUP HOLDINGS (935.HK) 1H 2013 Review: Bucked the Trend. Company Profile. 1-Yr Price Performance vs. HSI. Basic Share Information
20 August 2013 LOGISTIC SERVICES DRAGON CROWN GROUP HOLDINGS (935.HK) BUY TARGET Maintain HK$1.30 Previous Target HK$1.30 Consensus Target N/A Current (19/8/2013) HK$0.98 Upside 33% Market Cap. HK$1,087.5M
More informationBUY. China Suntien Green Energy [0956.HK] January 25, 2016
China Suntien Green Energy [0956.HK] Profit decline largely due to provision; Current valuation of 0.4x PBR already reflected significant impairment Suntien preannounced that its net profit in 2015 would
More informationBUY CMEC [1829.HK] July 23, Impact from longer-than-expected suspension of Iraq power project. Infrastructure Sector
CMEC [9.HK] Impact from longer-than-expected suspension of Iraq power project We expect H net income to decline by 7% because of Iraq power project suspension since June. After discussing with management,
More informationRecommendation: BUY. CIMC Enric Holdings Ltd. (3899.HK) 18 August 2014 TP: HK$14.2 (+42.7%) SECTION 1 RESULTS BRIEFING SECTION 2 COMPANY BACKGROUND
Recommendation: BUY TP: HK$14.2 (+42.7%) CIMC Enric Holdings Ltd. (3899.HK) 18 August 2014 SECTOR: Oil & Gas equipment HSI: 24,955.46 PRICE: HK$9.95 EARNINGS (reported in RMBm) KEY DATA For the fiscal
More informationCompany Update. China Oriental Group (581 HK) Rating: Buy; TP: HK$8.4. HK equity market China Materials Steel. 04 Sep Reverse NDR Takeaways
Company Update HK equity market China Materials Steel China Oriental Group (581 HK) Reverse NDR Takeaways Last week, we hosted a reverse NDR with China Oriental Group (COG) in Shanghai, which was generally
More informationCompany Report. TCL Comm (2618 HK) NDR takeaways: Conservative shipment outlook; Positive on stable margin NEUTRAL WHAT S NEW N/A.
Company Report China Merchants Securities (HK) Co., Ltd. Hong Kong Equity Research TCL Comm (2618 HK) NDR takeaways: Conservative shipment outlook; Positive on stable margin Expect FY15E Smartphone/tablets/feature
More informationDim Sum Express. Hong Kong Market. Equity Research. Feb 5, 2018
Equity Research Dim Sum Express Key index performance Chg (%) EPS (%) P/E Market 1D 1M YTD 17E 18E 17E 18E HSI -0.1 5.8 9.0 42.8 10.5 12.7 11.5 HSCEI 0.8 10.9 15.6 31.8 10.8 8.6 7.7 MXCN -0.5 4.3 10.2
More informationChina Puti. Universal Medical (2666 HK) Essential player in China s public hospital reform. Visit Note. Not Rated HK$6.77
Universal (2666 HK) China Puti Essential player in China s public hospital reform Rating Current Price Not Rated HK$6.77 Integrated healthcare services, spurred by healthcare reform Healthcare resources
More informationDaewoong Pharmaceutical (069620)
Earnings Review July 31, 2014 12M rating BUY (Maintain) 12M TP W85,000 from W85,000 Up/downside +44% Stock Data KOSPI (Jul 30, pt) 2,083 Stock price (Jul 30, KRW) 58,900 Market cap (USD mn) 666 Shares
More informationSunny Optical 2382.HK. Competition disruptive to GPM
Mar-12 Jun-12 Sep-12 Dec-12 Mar-13 Jun-13 Sep-13 Dec-13 Mar-14 Sunny Optical 2382.HK Competition disruptive to GPM Slightly disappointing FY13 results Sunny Optical reported a FY13 results with 45.9% yoy
More informationTCL Communication (2618 HK) Painful transition period. Buy (Maintain) Target Price HK$2.33 Up/downside +28.5% Current price HK$1.
Securities Analysis (Equity) TCL Communication (218 HK) Painful transition period 1H12 profit warning. TCL Com announced profit warning on 15 Jul and expected to record a significant drop in 2Q12 net profit
More informationE 2016E 2017E
November 26, 2015 Sinosoft Technology Group [1297.HK] A beneficiary of establishing carbon trading platform. BUY The development of the sales tax refund system for overseas visitors is in line with Sinosoft
More informationXinao Gas (2688) Hold January 17, Company update. Short-term uncertainty- negative for city gas sector
Xinao Gas (2688) Company update Hold January 17, 2006 Short-term uncertainty- negative for city gas sector NDRC endorsed the cancellation of connection fee in Guangdong. NDRC issued an official statement
More informationNet Profit 5,051 4,588 4,641 (8.1)% 1.1% 14,208 15, %
RESULTS REVIEW Share Data Market Cap Rs. 83 bn Price Rs. 202.5 BSE Sensex 15,566.10 Reuters Bloomberg Avg. Volume (52 Week) CNBK.BO CBK IN 0.1 mn 52-Week High/Low Rs. 421.45 / 198.05 Shares Outstanding
More informationDim Sum Express. A-Share Market. Hong Kong Market. Equity Research. Aug 5, 2014
Equity Research Dim Sum Express Alex Fan, CFA Head of Research SFC CE No. ADJ672 alexfan@gfgroup.com.hk +852 3719 1047 Ryan Zhu Research Analyst SFC CE No. BDK820 zhuran@gfgroup.com.hk +86 0755 88263160
More informationJiangnan Group (1366 HK)
Jiangnan Group (1366 HK) Target price: N/A Previous TP: N/A Last price: HK$2.42 China / Industrial Goods/ Company Visit Note Potential Return: N/A Targeting to be the No.1 in three years Benefit from the
More informationDim Sum Express. A-Share Market. Hong Kong Market. Equity Research. Feb 16, 2017
Equity Research Dim Sum Express Key index performance Chg (%) EPS (%) P/E Market 1D 1M YTD 16E 17E 16E 17E HSI 1.2 5.6 9.1-11.4 9.0 12.0 11.0 HSCEI 1.8 8.0 11.1-14.7 8.2 8.5 7.8 MXCN 1.1 7.1 11.3-15.5
More information